Home/Filings/4/0001610717-25-000254
4//SEC Filing

Martell Bridget A 4

Accession 0001610717-25-000254

CIK 0001799448other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:29 PM ET

Size

5.3 KB

Accession

0001610717-25-000254

Insider Transaction Report

Form 4
Period: 2025-06-25
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-25+5,8605,860 total
    Exercise: $7.63Exp: 2035-06-25Common Stock (5,860 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2026 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.

Documents

1 file

Issuer

Aligos Therapeutics, Inc.

CIK 0001799448

Entity typeother

Related Parties

1
  • filerCIK 0001629627

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:29 PM ET
Size
5.3 KB